Implications of the cytosolic phospholipase A2 knockout mouse on perioperative therapeutics.
Sapirstein
Adam
A
Anesthesiology and Critical Care Medicine, Johns Hopkins, Baltimore, MD 21287, USA.
D000818:Animals; D002545:Brain Ischemia / Q000209:etiology; D003600:Cytosol / Q000201:enzymology*; D015777:Eicosanoids / Q000502:physiology; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D008168:Lung / Q000502:physiology; D020267:MPTP Poisoning / Q000209:etiology; D051379:Mice; D018345:Mice, Knockout; D010741:Phospholipases A / Q000037:antagonists & inhibitors / Q000502:physiology*; D054467:Phospholipases A2
D015777:Eicosanoids; D004791:Enzyme Inhibitors; D010741:Phospholipases A; D054467:Phospholipases A2